androstane-3,17-diol has been researched along with Hormone-Dependent Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adamski, J; Breitling, R; Krazeisen, A; Möller, G | 1 |
1 other study(ies) available for androstane-3,17-diol and Hormone-Dependent Neoplasms
Article | Year |
---|---|
Human 17beta-hydroxysteroid dehydrogenase type 5 is inhibited by dietary flavonoids.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Androstane-3,17-diol; Androstenedione; Androsterone; Anticarcinogenic Agents; Binding Sites; Diet; Enzyme Inhibitors; Estrogens, Non-Steroidal; Flavonoids; Humans; Hydroxylation; Hydroxyprostaglandin Dehydrogenases; Isoflavones; Neoplasms, Hormone-Dependent; Oxidation-Reduction; Phytoestrogens; Plant Preparations; Plants, Edible; Recombinant Fusion Proteins; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Tamoxifen; Testosterone | 2002 |